TTRX
TTRX clinical trials: Turn Therapeutics Inc.
Every trial on ClinicalTrials.gov where Turn Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 2
- Trials linked
- 2
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
TTRX on the catalyst calendar · TTRX registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jan 20, 2027Sponsor estimate | NCT07355075A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate...Turn Therapeutics · Eczema Atopic Dermatitis | TTRXLead | Phase 2/Phase 3 | Recruiting | Locked | Locked | Locked |
| May 30, 2021Actual | NCT04951349Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.Turn Therapeutics · Covid19 | TTRXLead | Phase 2 | Completed | Locked | Locked | Locked |
- Primary completion Jan 20, 2027Sponsor estimatePhase 2/Phase 3NCT07355075A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate...Turn Therapeutics · Eczema Atopic DermatitisRecruitingTTRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2021ActualPhase 2NCT04951349Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.Turn Therapeutics · Covid19CompletedTTRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 2 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner